Clinical Trial Update: Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a combination of decitabine, doxorubicin, and cyclophosphamide in children with relapsed or refractory solid tumors or neurobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Dacogen (decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED